SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Reports Clinical Benefits for Diranersen Across Studied Doses

Biogen said the 60 mg dose group showed compelling efficacy and a favorable benefit-risk profile.

BIIB

Related stories